Kyowa Kirin Co Ltd (4151):企業の財務・戦略的SWOT分析

◆英語タイトル:Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1686
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥14,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Kyowa Kirin Co Ltd (4151) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Kyowa Kirin Co Ltd (Kyowa Kirin), a subsidiary of Kirin Holdings Company Limited, is a research and development based biotechnology company. It focuses on the discovery, development, production and commercialization of pharmaceuticals and biotechnology products. The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others. Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and others. The company operates through a network of subsidiaries in the US, Europe and Asia. Kyowa Kirin is headquartered in Tokyo, Japan.

Kyowa Kirin Co Ltd Key Recent Developments

Feb 05,2020 Kyowa Kirin announces its organization changes
Nov 27,2019 Ardelyx and Kyowa Kirin expand drug development partnership
Nov 26,2019 Kyowa Kirin announces organizational changes in quality assurance and pharmacovigilance functions
Jul 01,2019 Kyowa Kirin Corporate Website Renewal

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Kyowa Kirin Co Ltd – Key Facts
Kyowa Kirin Co Ltd – Key Employees
Kyowa Kirin Co Ltd – Key Employee Biographies
Kyowa Kirin Co Ltd – Major Products and Services
Kyowa Kirin Co Ltd – History
Kyowa Kirin Co Ltd – Company Statement
Kyowa Kirin Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Kyowa Kirin Co Ltd – Business Description
Geographical Segment: Americas
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other
Performance
R&D Overview
Kyowa Kirin Co Ltd – Corporate Strategy
Kyowa Kirin Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Kyowa Kirin Co Ltd – Strengths
Kyowa Kirin Co Ltd – Weaknesses
Kyowa Kirin Co Ltd – Opportunities
Kyowa Kirin Co Ltd – Threats
Kyowa Kirin Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Kyowa Kirin Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 05, 2020: Kyowa Kirin announces its organization changes
Nov 27, 2019: Ardelyx and Kyowa Kirin expand drug development partnership
Nov 26, 2019: Kyowa Kirin announces organizational changes in quality assurance and pharmacovigilance functions
Jul 01, 2019: Kyowa Kirin Corporate Website Renewal
Feb 05, 2019: Kyowa Hakko Kirin announces changes in global management structure
Feb 05, 2019: Kyowa Hakko Kirin announces organizational changes
Feb 05, 2019: Kyowa Hakko Kirin announces changes in the Executive Directors
Feb 05, 2019: Kyowa Kirin Announces CI Logotype Change
Feb 05, 2019: Kyowa Hakko Kirin announces consolidated financial results for the fiscal year ended December 31, 2018
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Kyowa Kirin Co Ltd, Key Facts
Kyowa Kirin Co Ltd, Key Employees
Kyowa Kirin Co Ltd, Key Employee Biographies
Kyowa Kirin Co Ltd, Major Products and Services
Kyowa Kirin Co Ltd, History
Kyowa Kirin Co Ltd, Other Locations
Kyowa Kirin Co Ltd, Subsidiaries
Kyowa Kirin Co Ltd, Joint Venture
Kyowa Kirin Co Ltd, Key Competitors
Kyowa Kirin Co Ltd, Ratios based on current share price
Kyowa Kirin Co Ltd, Annual Ratios
Kyowa Kirin Co Ltd, Annual Ratios (Cont...1)
Kyowa Kirin Co Ltd, Annual Ratios (Cont...2)
Kyowa Kirin Co Ltd, Interim Ratios
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Kyowa Kirin Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Kyowa Kirin Co Ltd, Performance Chart (2015 - 2019)
Kyowa Kirin Co Ltd, Ratio Charts
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Kyowa Kirin Co Ltd (4151):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Swift Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company’s products include 2S hyb DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …
  • Gannett Co Inc (GCI):企業の財務・戦略的SWOT分析
    Gannett Co Inc (GCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Genesis Healthcare, Inc.:戦略・SWOT・企業財務分析
    Genesis Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genesis Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Walker Greenbank PLC:企業の戦略・SWOT・財務情報
    Walker Greenbank PLC - Strategy, SWOT and Corporate Finance Report Summary Walker Greenbank PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Cancer Research UK-製薬・医療分野:企業M&A・提携分析
    Summary Cancer Research UK (CRUK) is a research institution which offers clinical research services to treat cancer. The institute offers research services for womb cancer, lung cancer, bladder cancer, bone cancer, bowel cancer, brain tumours, breast cancer, carcinoid, cervical cancer, children's ca …
  • Freudenberg & Co KG:企業の戦略的SWOT分析
    Freudenberg & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Guangzhou Wondfo Biotech Co Ltd (300482):製薬・医療:M&Aディール及び事業提携情報
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that develops, manufactures and supplies rapid diagnostic reagents and related equipment. Its products include rapid quantitative test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo also of …
  • Nutra Pharma Corp (NPHC):企業の財務・戦略的SWOT分析
    Nutra Pharma Corp (NPHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • C’Bon Cosmetics Co Ltd:企業の戦略・SWOT・財務情報
    C'Bon Cosmetics Co Ltd - Strategy, SWOT and Corporate Finance Report Summary C'Bon Cosmetics Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Chesswood Group Ltd (CHW):企業の財務・戦略的SWOT分析
    Chesswood Group Ltd (CHW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bang & Olufsen AS:企業の戦略・SWOT・財務情報
    Bang & Olufsen AS - Strategy, SWOT and Corporate Finance Report Summary Bang & Olufsen AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • McRae Industries, Inc.:企業の戦略・SWOT・財務情報
    McRae Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary McRae Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Halozyme Therapeutics Inc (HALO):医療機器:M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • Sao Martinho SA (SMTO3):企業の財務・戦略的SWOT分析
    Sao Martinho SA (SMTO3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Kratos Defense & Security Solutions, Inc.:企業の戦略・SWOT・財務情報
    Kratos Defense & Security Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kratos Defense & Security Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Abbott Diagnostics:企業の製品パイプライン分析2018
    Summary Abbott Diagnostics, a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers core laboratory products, molecular point of care products, transfusion medicine, professional services and diagnostics portfolio. Its products include labo …
  • Sanwa Holdings Corporation:企業の戦略・SWOT・財務情報
    Sanwa Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Sanwa Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Gulf Power Co:電力:M&Aディール及び事業提携情報
    Summary Gulf Power Co (Gulf Power), a subsidiary of Southern Company, is an integrated energy utility. It generates, procures, transmits, and distributes electricity. The company produces electricity using coal and gas sources. Through agreements with industrial, commercial, and qualifying facilitie …
  • Grupo Bimbo, S.A.B. de C.V. (BIMBOA):企業の財務・戦略的SWOT分析
    Grupo Bimbo, S.A.B. de C.V. (BIMBOA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • QuantuMDx Group Ltd:企業の製品パイプライン分析
    Summary QuantuMDx Group Ltd (QuantuMDx) is a developer of sciences tools and diagnostics products. The company’s products include Q-POC, a handheld DNA analyzer that provides an accurate molecular diagnostic results. It develops assays for diagnosis and drug susceptibility testing of infectious dise …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆